Literature DB >> 8280851

Increased expression of heat-shock protein 27 kDa in Alzheimer disease: a preliminary study.

K Renkawek1, G J Bosman, M Gaestel.   

Abstract

Stress-response (heat shock) proteins (hsps) are induced in living cells under pathological conditions, including diseases of the central nervous system. Increased synthesis of hsps is suggested to play a role in preventing neuronal injury in Alzheimer disease (AD). Using a highly specific antibody we have studied the expression of heat shock protein 27 kDa (hsp 27), in the brains of AD and non-demented, age-matched control patients. Immunoblotting and immunohistochemical methods were used. We report here that in the human brain in the normal condition the expression of hsp 27 is low and limited to the vessels, subpial astrocytes and single astrocytes of the white matter. There is a significant increase in the expression of hsp 27 in the cortex of AD. In AD, the immunoreaction is mainly localized in proliferating astrocytes establishing a pattern of astrocytic gliosis. These findings are the first to show the presence of hsp 27 in human cerebral tissue in normal conditions and its induction in AD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280851     DOI: 10.1097/00001756-199310000-00003

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  23 in total

1.  Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.

Authors:  Amanda M Gleixner; Jessica M Posimo; Deepti B Pant; Matthew P Henderson; Rehana K Leak
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

2.  Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo.

Authors:  D Pubill; E Verdaguer; A M Canudas; F X Sureda; E Escubedo; J Camarasa; M Pallàs; A Camins
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

3.  Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Georgianne F Tiu; Nicole N Scheff; Marzia Perluigi; Chiara Cini; D Allan Butterfield
Journal:  Brain Res       Date:  2010-04-01       Impact factor: 3.252

4.  Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia.

Authors:  K Renkawek; G J Bosman; W W de Jong
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  N-Acetyl-l-Cysteine Protects Astrocytes against Proteotoxicity without Recourse to Glutathione.

Authors:  Amanda M Gleixner; Daniel F Hutchison; Sara Sannino; Tarun N Bhatia; Lillian C Leak; Patrick T Flaherty; Peter Wipf; Jeffrey L Brodsky; Rehana K Leak
Journal:  Mol Pharmacol       Date:  2017-08-22       Impact factor: 4.436

Review 6.  Protein homeostasis and aging: The importance of exquisite quality control.

Authors:  Hiroshi Koga; Susmita Kaushik; Ana Maria Cuervo
Journal:  Ageing Res Rev       Date:  2010-02-10       Impact factor: 10.895

7.  Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

Authors:  M A Smith; R K Kutty; P L Richey; S D Yan; D Stern; G J Chader; B Wiggert; R B Petersen; G Perry
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 8.  Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door?

Authors:  Subhankar Paul; Sailendra Mahanta
Journal:  Mol Cell Biochem       Date:  2013-10-05       Impact factor: 3.396

9.  Heat shock proteins in neurodegenerative disorders and aging.

Authors:  Rehana K Leak
Journal:  J Cell Commun Signal       Date:  2014-09-11       Impact factor: 5.782

Review 10.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.